Cargando…

The prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy: Case report and review of literature

RATIONALE: Pancreatic neuroendocrine tumors (pNET) are rare slowly growing tumors with a high metastatic potential. Peptide receptor radionuclide therapy (PRRT) with radiolabeled analogues has been developed as a new tool for the management of metastatic well-differentiated (grade 1 and 2) neuroendo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montanier, Nathanaëlle, Joubert-Zakeyh, Juliette, Pétorin, Caroline, Montoriol, Pierre François, Maqdasy, Salwan, Kelly, Antony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313014/ https://www.ncbi.nlm.nih.gov/pubmed/28178157 http://dx.doi.org/10.1097/MD.0000000000006062

Ejemplares similares

Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population: A two-year experience in a nonuniversity setting
por: Mejia, Alejandro, et al.
Publicado: (2022)

Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
por: Lolli, Ivan, et al.
Publicado: (2017)

Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study
por: Ge, Lina, et al.
Publicado: (2021)

Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors: Case series
por: Müller, Christian, et al.
Publicado: (2022)

Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study
por: Li, Gang, et al.
Publicado: (2020)

Hemorrhagic disseminated intravascular coagulation after (177)Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report
por: Worbe, Noémie, et al.
Publicado: (2021)

The impact of propranolol on the growth and development of children with proliferative infantile hemangioma during treatment
por: Lin, Xiangshang, et al.
Publicado: (2023)

Update in clinical management for gallbladder neuroendocrine carcinoma
por: Chu, Hongwu, et al.
Publicado: (2021)

Rare clinical presentations of pleomorphic xanthoastrocytoma with a high proliferative index: Two case reports
por: Nagaishi, Masaya, et al.
Publicado: (2020)

The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapy
por: Hannan, Enda J., et al.
Publicado: (2017)

Well-differentiated neuroendocrine tumor of the stomach: A rare case at an uncommon site
por: Gumuscu, Burak, et al.
Publicado: (2016)

Neuroendocrine carcinoma of the nasal cavity with epiphora as the first symptom: A case report
por: Wu, Weiqi, et al.
Publicado: (2020)

Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study
por: Montanier, Nathanaëlle, et al.
Publicado: (2019)

Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
por: Lin, Liang-Yu, et al.
Publicado: (2017)

Synchronous multiple carcinoma with small intestine and pulmonary neuroendocrine involvement: A case report
por: Shan, Binbin, et al.
Publicado: (2017)

Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study
por: Zhu, Jiamin, et al.
Publicado: (2021)

Esophageal neuroendocrine tumor with initial presentation as painless forehead and neck masses: A case report
por: Chin, Yen-Po, et al.
Publicado: (2017)

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report
por: Liang, Jin-Yan, et al.
Publicado: (2017)

The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
por: Kim, Seung Tae, et al.
Publicado: (2016)

Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature
por: Tsoukalas, Nikolaos, et al.
Publicado: (2017)

The therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis
por: Wang, Li-fan, et al.
Publicado: (2020)

PD-L1 – inhibitors in neuroendocrine neoplasia: Results from a real-life study
por: Özdirik, Burcin, et al.
Publicado: (2021)

Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors: A retrospective study
por: Jiao, Xiaoxiao, et al.
Publicado: (2020)

Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis
por: Liu, Shenxiang, et al.
Publicado: (2021)

Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases: Large Data From Asia
por: Du, Shunda, et al.
Publicado: (2015)

Treatment, prognostic markers, and survival in thymic neuroendocrine tumors: A single center experience of 41 patients
por: Ma, Kefeng, et al.
Publicado: (2017)

Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues
por: Brieau, Bertrand, et al.
Publicado: (2015)

Gastroenteropancreatic—origin neuroendocrine carcinomas: Three case reports with favorable responses following localized radiotherapy and a review of literature
por: Won, Yong Gyun, et al.
Publicado: (2017)

Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature
por: Deng, Jian, et al.
Publicado: (2023)

Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report
por: Kumar, Amit, et al.
Publicado: (2022)

Giant mediastinal neuroendocrine tumor successfully resected after transarterial chemoembolization of drug-eluting embolic microspheres: A case report
por: Yu, Qi, et al.
Publicado: (2021)

Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019)

Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours
por: Lim, Lisi Elizabeth, et al.
Publicado: (2020)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
por: Elston, Marianne S., et al.
Publicado: (2021)

Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution
por: Yang, Min, et al.
Publicado: (2016)

The eighth version of American Joint Committee on Cancer nodal classification for high grade pancreatic neuroendocrine tumor should be generalized for the whole population with this disease
por: Li, Mu-xing, et al.
Publicado: (2020)

Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual
por: Deng, Ben-Yuan, et al.
Publicado: (2020)

Diagnostic performance and impact on patient management of [(68)Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut
por: Delabie, Pierre, et al.
Publicado: (2022)

Successful treatment of metastatic pheochromocytoma in the spine with cement augmentation
por: Cai, Siyi, et al.
Publicado: (2017)

Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
por: Yoo, Shin Hye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_geijkmd1rrj19nifcd1qnlcpnt